ClinicalTrials.govpublic full text
Safety and Dose-escalation Study of AAV2-hCHM in Participants With CHM (Choroideremia) Gene Mutations
choroideremia, chm (choroideremia) gene mutations, aav, gene therapy, chm, adeno-associated virus, adeno-associated viral vector, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 804093
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.